Aqneursa Side Effects

Generic name: levacetylleucine

Medically reviewed by Drugs.com. Last updated on Nov 10, 2024.

Note: This document provides detailed information about Aqneursa.

Applies to levacetylleucine: oral granules for oral suspension Side Effects associated with levacetylleucine. Some dosage forms listed on this page may not apply specifically to the brand name Aqneursa.

Applies to levacetylleucine: oral granules for oral suspension.

Side effects include:

Most common adverse reactions (≥5%): abdominal pain, dysphagia, upper respiratory tract infections, vomiting.

For healthcare professionals

Applies to levacetylleucine: oral granule for reconstitution.

General adverse events

Most common adverse reactions with a frequency of 5% or greater were abdominal pain, dysphagia, upper respiratory tract infections, and vomiting.^[Ref]

Dermatologic

• Common (1% to 10%): Rosacea exacerbation^[Ref]

Gastrointestinal

• Common (1% to 10%): Abdominal pain, dysphagia, vomiting^[Ref]

Hematologic

• Frequency not reported: Thrombocytopenia^[Ref]

Respiratory

• Very common (10% or more): Upper respiratory tract infection (17%)^[Ref]

See also:

Further information

Aqneursa side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer